Latest Breaking News On - Shankar musunuri - Page 21 : comparemela.com

Ocugen (OCGN) Enters Agreement With Washington University in St Louis for Commercialization of Intranasal COVID-19 Vaccine in US, Europe and Japan

Ocugen (OCGN) Enters Agreement With Washington University in St Louis for Commercialization of Intranasal COVID-19 Vaccine in US, Europe and Japan
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHerberts gasserDavidt curielShankar musunuriWashington universityWashington university school of medicineWashington university in stOcugen incChief executive officerWashington university schoolDistinguished professorRadiation oncology

Ocugen, Inc to Present at H C Wainwright 24th Annual Global Investment Conference

06.09.2022 - MALVERN, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) - Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, announced that Dr. .

New yorkUnited statesShankar musunuriOcugen incChief executive officerAnnual global investment conference

Ocugen Appoints Robert J Hopkins, MD, MPH & TM, FACP, FIDSA, as Chief Medical Officer and Promotes Arun Upadhyay, PhD, to Chief Scientific Officer

Ocugen Appoints Robert J Hopkins, MD, MPH & TM, FACP, FIDSA, as Chief Medical Officer and Promotes Arun Upadhyay, PhD, to Chief Scientific Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tarun upadhyayRobertj hopkinsShankar musunuriBiomedical advanced researchDrug administrationTiffany hamiltonhead of communicationsOcugen incResearch developmentDevelopment authorityDepartment of pharmaceutical sciencesExchange commissionDynport vaccine companyMerck research labsUniversity of colorado denverChief medicalSenior vice president

Ocugen, Inc (OCGN) Q2 2022 Earnings Call Transcript

OCGN earnings call for the period ending June 30, 2022.

United statesJennifer kim cantor fitzgeraldDaniil gataulinJennifer kimJessica crespoDaniil gataulin chardanCansino bioShankar musunuriJonathan aschoffExchange commissionTrademark officeHarvard medical schoolOcugen incTiffany hamilton head of corporate communicationsWorld vaccine congressTiffany hamilton

Ocugen Announces Publication of Positive Results of COVID-19 Vaccine Trial for Children 2-18 in The Lancet Infectious Diseases

21.06.2022 - Ocugen’s partner Bharat Biotech’s Phase 2/3 study of COVAXIN (BBV152) in 526 children showed safety, efficacy, and superior response to that shown in adults Ocugen has North American commercialization rights for COVAXIN MALVERN, Pa., June 21, . Seite 1

Andhra pradeshUnited statesShankar musunuriKrishna mohan vadrevuSiddharth reddyBharat biotech international limitedOcugen incLancet infectious diseasesNorth americaNorth americanBharat biotech